Status:
COMPLETED
Mortality in Non-cystic Fibrosis Bronchiectasis
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Non-cystic Fibrosis Bronchiectasis
Eligibility:
All Genders
18+ years
Brief Summary
In this study we analyzed the overall survival for all newly diagnosed patients with non-cystic fibrosis bronchiectasis from June 2006 onwards. The investigators wanted to confirm the known risk facto...
Eligibility Criteria
Inclusion
- Patients with clinically significant and radiologically proven bronchiectasis
- Chest CT scan confirming the presence of bronchiectatic lesions and had symptoms of chronic productive cough
- Bronchiectasis was deemed to be present if there was one or more of the following criteria: a bronchoarterial ratio greater than 1, lack of tapering of the bronchi and visualization of bronchi within 1 cm of costal or paravertebral pleura or abutting the mediastinal pleura
Exclusion
- diagnosis of cystic fibrosis
- underlying tumoral problem causing the bronchiectatic lesions (postradiotherapy, secondary immunodeficiency due to chemotherapy or postinfectious due to tumoral obstruction)
- patients with asymptomatic traction bronchiectasis caused by interstitial lung disease
Key Trial Info
Start Date :
June 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
253 Patients enrolled
Trial Details
Trial ID
NCT01792427
Start Date
June 1 2006
End Date
December 1 2012
Last Update
February 20 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Leuven
Leuven, Vlaams-Brabant, Belgium, 3000